1.A Case of Epidermal Cyst Occurred in the Bony External Auditory Canal Misdiagnosed as External Auditory Canal Carcinoma.
Sung Hwan LIM ; Beom Mo KOO ; Po Na PARK ; Hyun Sang CHO
Korean Journal of Otolaryngology - Head and Neck Surgery 2018;61(12):714-717
Epidermal cysts are generally benign tumors that usually originate from the skin caused by inflammation of hair cortex and proliferation of epidermal cells within the dermis; however, for these cysts to occur in the bony external auditory canal (EAC) is rare. They are often present as a solitary, painless lesion and usually asymptomatic and the diagnosis depends on the results of the histological examination. In treatment, the cyst wall must be completely removed surgically. We recently encountered a 82-year-old male with a mass in the right EAC. An otoscopic examination showed a polypoid mass on the bony EAC, which was finally diagnosed as epidermal cyst after an initial misdiagnosis as EAC carcinoma. We report the rare, unique case with literature review.
Aged, 80 and over
;
Dermis
;
Diagnosis
;
Diagnostic Errors
;
Ear Canal*
;
Epidermal Cyst*
;
Hair
;
Humans
;
Inflammation
;
Male
;
Skin
2.A Comparison of Epidural Analgesia using 0.1% Levobupivacaine or 0.2% Levobupivacaine Combined with Sufentanil after Major Abdominal Surgery.
Gyong Uk JIN ; Po Soon KANG ; Sung Mee JUNG ; Jeong Min PARK ; Chun Woo YANG ; Na Young KO
Korean Journal of Anesthesiology 2008;54(3):307-314
BACKGROUND: Continuous epidural analgesia with an opioid-local anesthetic combination is an effective strategy for postoperative pain relief after abdominal surgery. Levobupivacaine, the pure S (-) enantiomer of racemic bupivacaine, is similar to its native agent for anesthetic efficacy but has less cardiotoxic and neurotoxic potential than the bupivacaine. We compared the efficacy and safety of 0.1% levobupivacaine with sufentanil or 0.2% levobupivacaine with the same dose of suentanil for patient-controlled epidural analgesia after major abdominal surgery. METHODS: Forty patients scheduled for major abdominal surgery under general anesthesia were randomized to receive either 0.1% levobupivacaine with sufentanil 0.75microgram/ml (n = 20) or 0.2% levobupivacaine with sufentanil 0.75microgram/ml (n = 20) for postoperative epidural analgesia using a patient-controlled analgesia pump at a rate of 3 ml/h and bolus dose of 2 ml on demand. Visual analogue scale (VAS) pain scores at rest, on coughing, during mobilization from the supine to the sitting position and on ambulation were assessed during 48 hours following the surgery. In addition, degree of motor block and mobilization, additional analgesic requirements and adverse effects were assessed. RESULTS: There were no significant differences in VAS pain scores at rest, on coughing, during mobilization from the supine to the sitting position and on ambulation. There were no significant differences in mean volume of local anesthetic consumption, additional analgesic requirements, degree of motor block and mobilization and the incidence of adverse effects. CONCLUSIONS: 0.1% levobupivacaine with sufentanil provided comparable postoperative epidural analgesia and incidences of adverse effects to 0.2% levobupivacaine with the same dose of suentanil in patients undergoing major abdominal surgery.
Analgesia, Epidural
;
Analgesia, Patient-Controlled
;
Anesthesia, General
;
Bupivacaine
;
Cough
;
Humans
;
Incidence
;
Pain, Postoperative
;
Sufentanil
;
Walking